# Mobix Labs, Inc: overview MOBX · Nasdaq · CIK 1855467 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/mobx.md) · [Financials](/companies/mobx/financials.md) · [Filings](/companies/mobx/filings.md) · [Insiders](/companies/mobx/insiders.md) Latest reported revenue: [$789.0k](/filings/0001493152-26-038848.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 18, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-038848). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [3.0 d](/filings/0001493152-26-001921.md) | [3.2](/filings/0001493152-26-006406.md) | [2.5](/filings/0001493152-26-024661.md) | [2.4](/filings/0001493152-26-038848.md) | [1.9 d](/filings/0001493152-26-001921.md) | [1.9](/filings/0001493152-26-006406.md) | [1.0](/filings/0001493152-26-024661.md) | [0.8](/filings/0001493152-26-038848.md) | | Gross margin | % | [56.6% d](/filings/0001493152-26-001921.md) | [53.2%](/filings/0001493152-26-006406.md) | [40.6%](/filings/0001493152-26-024661.md) | [57.4%](/filings/0001493152-26-038848.md) | [50.5% d](/filings/0001493152-26-001921.md) | [31.0%](/filings/0001493152-26-006406.md) | [19.0%](/filings/0001493152-26-024661.md) | [12.9%](/filings/0001493152-26-038848.md) | | Operating margin | % | [(379.7%) d](/filings/0001493152-26-038848.md) | [(461.7%)](/filings/0001493152-26-006406.md) | [(311.7%)](/filings/0001493152-26-024661.md) | [(343.4%)](/filings/0001493152-26-038848.md) | [(380.7%) d](/filings/0001493152-26-038848.md) | [(471.1%)](/filings/0001493152-26-006406.md) | [(627.9%)](/filings/0001493152-26-024661.md) | [(932.1%)](/filings/0001493152-26-038848.md) | | Net margin | % | [(390.6%) d](/filings/0001493152-26-001921.md) | [(626.0%)](/filings/0001493152-26-038848.md) | [(91.2%)](/filings/0001493152-26-038848.md) | [(352.0%)](/filings/0001493152-26-038848.md) | [(835.8%) d](/filings/0001493152-26-001921.md) | [(540.0%)](/filings/0001493152-26-038848.md) | [(603.4%)](/filings/0001493152-26-038848.md) | [(2128.6%)](/filings/0001493152-26-038848.md) | | Diluted EPS | $ per share | not reported | [(0.52)](/filings/0001493152-26-006406.md) | [(0.57)](/filings/0001493152-26-024661.md) | [(1.70)](/filings/0001493152-26-038848.md) | not reported | [(0.16)](/filings/0001493152-26-006406.md) | [(0.59)](/filings/0001493152-26-024661.md) | [(1.33)](/filings/0001493152-26-038848.md) | | Free cash flow | $m | [32.1 d](/filings/0001493152-26-038848.md) | not reported | not reported | [(4.1) d](/filings/0001493152-26-038848.md) | [15.7 d](/filings/0001493152-26-038848.md) | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | [1.2](/filings/0001493152-24-051917.md) | [6.4](/filings/0001493152-26-001921.md) | [9.9](/filings/0001493152-26-001921.md) | | Gross margin | % | not reported | [(32.4%)](/filings/0001493152-24-051917.md) | [39.6%](/filings/0001493152-26-001921.md) | [50.5%](/filings/0001493152-26-001921.md) | | Operating margin | % | not reported | [(2903.9%)](/filings/0001493152-24-051917.md) | [(720.2%)](/filings/0001493152-26-038848.md) | [(380.3%)](/filings/0001493152-26-038848.md) | | Net margin | % | not reported | [(3237.0%)](/filings/0001493152-24-051917.md) | [(311.0%)](/filings/0001493152-26-001921.md) | [(465.4%)](/filings/0001493152-26-001921.md) | | Diluted EPS | $ per share | not reported | [(2.71)](/filings/0001493152-24-051917.md) | [(0.75)](/filings/0001493152-26-001921.md) | [(1.01)](/filings/0001493152-26-001921.md) | | Free cash flow | $m | not reported | not reported | [18.3](/filings/0001493152-26-038848.md) | [10.1](/filings/0001493152-26-038848.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mobx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $964.2k | 459,158 | | New +459,158 | | [Vanguard Capital Wealth Advisors](/funds/1730578.md) | 2026-06-30 | $427.9k | 203,774 | | New +203,774 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $337.5k | 160,720 | | New +160,720 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $235.0k | 111,880 | | New +111,880 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $195.2k | 92,934 | | New +92,934 | | [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $185.2k | 88,209 | | New +88,209 | | [Alessandra Capital Management, LLC](/funds/2132506.md) | 2026-06-30 | $144.5k | 68,789 | | New +68,789 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $109.3k | 52,049 | | New +52,049 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $71.5k | 34,045 | | New +34,045 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $53.0k | 25,231 | | New +25,231 | ## Recent filings [All 418 filings](/companies/mobx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-19 | 20:29 ET | [8-K](/filings/0001493152-26-047589.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-047589 | | 2026-10-16 | 21:13 ET | [8-K](/filings/0001493152-26-047449.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-047449 | | 2026-10-09 | 21:15 ET | [8-K](/filings/0001493152-26-046594.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-046594 | | 2026-10-05 | 23:20 ET | [8-K](/filings/0001493152-26-045639.md) | 5.07 Shareholder vote results | 0001493152-26-045639 | | 2026-09-14 | 23:54 ET | [DEF 14A](/filings/0001493152-26-042442.md) | Proxy statement, period 2026-09-11 | 0001493152-26-042442 | | 2026-08-31 | 21:22 ET | [8-K](/filings/0001493152-26-040870.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-040870 | | 2026-08-28 | 21:31 ET | [S-1](/filings/0001493152-26-040664.md) | Registration statement | 0001493152-26-040664 | | 2026-08-28 | 21:23 ET | [8-K](/filings/0001493152-26-040658.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-040658 | | 2026-08-18 | 01:18 ET | [10-Q](/filings/0001493152-26-038848.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038848 | | 2026-08-13 | 20:15 ET | [8-K](/filings/0001493152-26-037774.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037774 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001493152-26-001921.md), filed Jan 13, 2026. ## Forecast league Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/2fd93cd9-67b5-4b3b-94b7-660da9afe55f) ## About the filer - CIK: 1855467 - Tickers: MOBX, MOBXW - Exchange: Nasdaq - SIC code: 3674 Semiconductors & Related Devices - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.